Journal
CURRENT STEM CELL RESEARCH & THERAPY
Volume 11, Issue 2, Pages 114-121Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574888X10666150531173448
Keywords
Blood; hematopoietic cells; induced pluripotent stem cells; Mesenchymal stem cells; reprogramming
Categories
Funding
- Loma Linda University School of Medicine GCAT award
- USAMRAA Grant [W81XWH-12-1-0023]
Ask authors/readers for more resources
Mesenchymal stem cells (MSCs) have been successfully used to treat multiple diseases in animal studies and clinical trials. Currently, the commonly used MSCs are derived from bone marrow and adipose tissue. Alternative approaches include differentiation of induced pluripotent stem cells (iPSCs) into MSCs, or direct reprogramming of blood cells into MSCs. This review summarizes recent progresses concerning how to generate MSCs by blood cell reprogramming and how studies in cellular reprogramming may help identify new factors to expand or even rejuvenate adult MSCs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available